| 4-HNE | 4-hydroxynenal |
| 5-HIAA | 5-hydroxyindoleacetic acid |
| 5-HT2A | 5-hydroxytryptamine receptor 2A |
| ACEI | Angiotensin-converting enzyme inhibitors |
| ACTH | Adrenocorticotrophin |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate |
| ANP | Atrial natiuretic peptide |
| ARBs | Angiotensin receptor blockers |
| AREs | antioxidant response elements |
| ARNIs | Angiotensin receptor-neprilysin inhibitor |
| AVP | Arginine vasopressin |
| BAP | biological antioxidant potential |
| BDNF | Brain-derived neurotrophic factor |
| BH4 | Tetrahydrobiopterin |
| BNP | B-type natiuretic peptide |
| CCL2 | CC-chemokine ligand 2 |
| cGMP | Cyclic GMP |
| CNP | C-type natiuretic peptide |
| CNS | Central nervous system |
| CO | carbon monoxide |
| CRH | Corticotrophin-releasing hormone |
| CXCL1 | CXC-chemokine ligand 1 |
| d-ROMs | derivatives of reactive oxygen metabolites |
| EAE | experimental autoimmune encephalomyelitis |
| ER | estrogen receptor |
| ETC | electron transport chain |
| FSH | Follicle Stimulating Hormone |
| GABA | gamma-aminobutyric acid |
| GAD | glutamic acid decarboxylase |
| GC | guanylyl cyclase |
| Gpxs | glutathione peroxidases |
| GR | Glucocorticoid receptor |
| HO-1 | Heme oxygenase 1 |
| HPA | Hypothalamic-pituitary-adrenal |
| HSD | hydroxysteroid dehydrogenase |
| IDO | indoleamine 2,3-dioxygenase |
| IFN-γ | interferon-gamma |
| IL | Interleukin |
| IL-1RA | interleukin-1 receptor antagonist |
| IL-1β | Interleukin-1beta |
| InhA | inhibin A |
| InhB | inhibin B |
| Keap1 | Kelch-like ECH-associated protein 1 |
| LPS | lipopolysaccharide |
| LTP | long-term potentiation |
| MAO-A | Monoamine oxidase-A |
| MAOIs | Monoamine oxidase inhibitors |
| MAPK | mitogen-activated protein kinase |
| MDA | Malonaldehyde |
| MDD | Major Depressive Disorder |
| MR | Mineralocorticoid receptor |
| mTORC1 | Mammalian target of rapamycin complex-1 |
| NE | norepinephrine |
| NMDA | N-methyl-D-aspartate |
| NO | nitric oxide |
| Nps | natiuretic peptides |
| Nrf2 | nuclear respiratory factor 2 |
| O2− | oxide ion |
| ox LDL | oxidized lipoproteins |
| PFC | Prefrontal cortex |
| PLCγ1 | phospholipase Cγ1 |
| POMC | Pro-opiomelanocortin mRNA |
| PVN | Paraventricular nucleus |
| RAAS | renin–angiotensin–aldosterone system |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| SAR | superoxide anion radicals |
| SERM | Selective estrogen receptor modulators |
| sMaf | small musculoaponeurotic fibrosarcoma |
| SNRIs | Serotonin/norepinephrine reuptake inhibitors |
| SSRIs | Selective serotonin reuptake inhibitors |
| TAK1 | TGF-β activated kinase 1 |
| TCAs | Tricyclic antidepressants |
| TNF-α | Tumor necrosis factor-alpha |
| TrkB | Tyrosine kinase receptor B |